Agencies that design and sell insurance need a licensed insurer to issue the policies. Hippo's insurers, led by Spinnaker, do that for dozens of agencies, and it sells home insurance too.
The company · 2 · What exactly does it sell?
Premiums kept are most of revenue
Each $1 of sales, second quarter of 2026
82%13%5%
Premiums it keepsFees and commissionsInvestment income
Hippo passes most of the risk on to other insurers, so it books only the share it keeps.
The company · 3 · How does it make money?
A fee for lending its licence, plus premiums
About 30%of what it writes is kept
$498.1Mpolicies written last quarter
52agency programmes
Hippo earns a fee for issuing policies and keeps a slice of the risk and the premium.
Is it a good business? · 4 · What gives it an edge?
Licences and a rating agencies rent
50 states
Spinnaker's licences, rated A-
52 from 26
programmes in five quarters
+79%
growth in existing programmes
Partners stay and add programmes, but lending a licence is not rare.
Is it a good business? · 5 · What is the catch?
Lending a licence is not rare
Markeldoes the same for $1.9B a year
Allstate, Travelershome insurers, better ratings
HCIhome insurance rival
Listed rivals: MKL · ARX · ALL · TRV
The sharpest risk is Accelerant's programme moving to another insurer.
Is it a good business? · 6 · What does its record show?
Revenue grew six times; profit turned thin
Sales, $M
91.2
119.7
209.7
372.1
468.6
542.6
Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025last 12 mo
Sales$91.2M → $543Mrevenue, 2021 to the past year
Profit−407% → 5.9%net profit per $1
Share pay52% → 4.8%of revenue paid in shares
Costs fell from 53.3% to 45.4% of premiums in six quarters.
Is it a good business? · 7 · How much room is there to grow?
Lending licences is a large, growing market
About $128Bsold by agencies in the US, 2025
12%yearly growth
About $1.1Bwritten by Hippo in 2025
About a fifth of agency insurance is issued on a borrowed licence.
Is it a good business? · 8 · Who is in charge?
A long-serving leader, big outside holders
2.17%owned by chief Rick McCathron
11.4%held by the firm Talkot
25%of the chief's equity vests on three-year stock return
Those shares vest only if Hippo's stock beats other insurance technology companies.
The story right now · 9 · What is an insurance technology company?
Startups promised cheaper insurance through software
+60%Hippo's policies written
About 6%earned on what owners own
Thoma Bravobuying a key partner
A wave of startups promised to sell insurance more cheaply with software. Hippo began as one, selling home insurance, and now also lends its licences, which drives its growth.
The story right now · 10 · How much does Hippo really earn?
Most of the profit is on an adjusted measure
Policies grow fast+60%.
Adjusted profit $20.0MA quarter.
Reported profit $8.8MLess than half.
About 6% on net worthThin.
We value it on net worth and the earnings above an 8% return, which are still thin.
The story right now · 11 · What changed lately?
Policies up 60% and the forecast rose
$498.1Mpolicies written
$8.8Mreported profit
$20.0Mon the adjusted measure
33% → 30%share of premium Hippo keeps, falling in 2027
Solid quarter
Accelerant, a big partner, is being sold to Thoma Bravo in the first half of 2027, and its new owner could move the programme.
The story right now · 12 · What is everyone arguing about?
A profitable insurer, or a thin slice?
Many investors think
A home insurer turned profitable and fast-growing
We think
The price already pays for the 2028 plan
We would be wrong if reported profit passes $25M a quarter.
The price and our view · 13 · What is a share worth?
The price pays for the 2028 plan
$20.90what we think a share is worth · the last close is of that
$20.90our value
Neutral
Unattractive above $25.08
$17.10gloomy: net worth grows half as fast
$20.90our estimate: returns as planned
$48.24sunny: net worth grows a quarter faster
Value per share in three futures. None is a prediction of the share price.
We value an insurer on what it earns on its net worth over many years. Our rule: buy only when the price is at least a fifth below our estimate, as a cushion for being wrong.
The price and our view · 14 · How could we be wrong?
A big partner's new owner could leave
Accelerant could leaveBiggest
A new owner decides.
Storms and firesWatch
Home losses swing.
Adjusted is not reportedShowing now
Reported profit trails.
The licence feeUnknown
Not disclosed.
One programme drives its casualty business, and fees could fall.
The price and our view · 15 · How will we know?
February brings the 2027 forecast
Claims and costs below premiumsGood sign
Reported profit above $25M a quarterWe turn positive
Accelerant moves its programmeBad sign
FEB 202726
Fourth-quarter 2026 results, 26 February. Companies report every three months; each report is a test of the story.
Our view also changes on price alone: if the shares fall to within a fifth of our estimate, we move to Neutral.
The price and our view · 16 · So, what do we think?
Lending its licences, priced for its 2028 plan
$20.90our value
Neutral
Unattractive above $25.08
UnattractiveMedium conviction
Hippo's insurance grew 60% and costs fell fast, but it keeps only about 30% of what it writes and most profit is on its adjusted measure. What it earns on its net worth is still thin.
↑ ↓ to move · C for contents
What it does
More about the company
Who it is
Many insurance products are designed and sold by agencies called MGAs, which have the customers and the know-how but no insurance company of their own. They rent one: a licensed, rated carrier issues the policies under its name, a practice called fronting.
Hippo's carriers, led by Spinnaker, do that for dozens of agencies, from casualty to small-business cover. Hippo also sells its own home insurance. The alternatives for an agency are Markel's State National and other carriers, or building its own.
How it makes money
Hippo earns three ways: what customers pay for the share of risk it keeps, a fee on the rest, which it passes to reinsurers, and interest on the money it holds before claims are paid. In the quarter to June 2026 it wrote $482.2M of policies and kept $183.2M of them. Casualty and small-business programmes were two-thirds of what it wrote, and they are the lines where it keeps the least.
Growth and profit
What growth costs
Growth is getting cheaper. Costs fell from 53.3 to 45.4 cents per dollar customers pay over six quarters while policies written grew 61%. Reported profit still trails the adjusted measure by stock pay and amortisation of about $42M a year.
Its record
The numbers
Is it growing?Steady
Sales grew 21% over the twelve months to Sep 2026, slower than the 26% in the year to Dec 2025.
Is it profitable?Thin
It keeps 5.9% of sales as profit, up from −130% in the year to Dec 2023.
How steady is it?Swingy
Yearly sales growth has ranged from +26% to +77% over the last 5 years.
Does it earn good returns?Low
Shareholders' money earned 7.2% a year, up from −113% in the year to Dec 2021.
Is it making cash?Strong
It turned 23% of sales into free cash, $127M over the last twelve months.
Is profit turning into cash?Real cash
Free cash flow was 4.0 times net income.
Are shares being diluted?Diluting
The share count rose 148% in 4.8 years, and pay in shares costs 4.8% of sales.
Why it wins
The evidence
An agency cannot write insurance without a licensed carrier, approved rates in each state and a rating brokers accept. Spinnaker has licences in every state and an A- rating, so agencies rent it, and once their policies sit on its paper, moving them means filing everything again.
The sign that partners stay: Hippo ran 52 programmes in mid-2026 against 26 five quarters earlier, most added by partners already there, and those existing programmes grew 79%.
Who could beat it
The rivals in full
Renting paper is not rare. Markel's State National fronts $1.9B a year, and larger home insurers with better ratings compete for Hippo's own customers. The sharpest risk is Accelerant: its new private owner could move its programme to its own or another carrier.
Each rival
Markel's State NationalMKL
fronting paper for the same MGAs, from a larger carrier rated A
Accelerant's own carriersARX
the Accelerant programme, if its new private owner writes it on its own paper or another carrier's
Allstate and Travelers homeowners policies, sold through agents and bundled with carALLTRV
Hippo's own homeowners policy, from rivals with higher ratings and more capital
State Farm, Liberty Mutual and Farmersnot listed
Hippo's own homeowners policy, from the mutual and private giants
How big it could get
The market and who has signed
The market
Conning, an insurance research firm, counts about $128B of insurance sold by MGAs in the US in 2025, growing 12% a year, with about a fifth of it written on rented paper: roughly $22.6B to $25.6B a year. Hippo wrote about $1.1B in 2025, so it has at most about 5% of that market.
Who has signed
Accelerant, an agency network, agreed to put more than $500M a year of policies on Hippo's paper from October 2026, on Hippo's statement; the agreement is not filed and its length is not disclosed. The other 52 programmes run on agreements that are not filed either.
Who runs it
Leaders, pay and the cash
Who runs it
Rick McCathron has been president since 2017 and chief executive since 2022, and owns 2.17%; officers and directors own 4.48% between them. Talkot, an investment firm, holds 11.4% and the Lennar Foundation, tied to the homebuilder, 8.0%.
Bonuses pay on revenue, reported net income and operating goals, and a quarter of the chief executive's shares vest on how the stock does against other insurtechs over three years.
What they did with the money
In 2025 Hippo sold the network that sold its policies through homebuilders, for a $95.0M gain. It bought back about $30M of stock across 2024 and 2025 and has bought none in 2026.
The last report
The latest report
Hippo's policies written grew 60% to $498.1M and the forecast rose again
What it did to the thesis Solid quarter
It met our test for growth, costs and the forecast. It left the profit question open: reported profit was well under adjusted, Hippo kept less of its policies, and Accelerant was not discussed.
The report
In the quarter to September 2026 Hippo wrote $498.1M of policies, 60% more than a year earlier, and revenue rose 29% to $156M. Claims and costs took 98.4 cents of each dollar customers paid, even with 6.5 points of storm losses. Reported net income was $8.8M against $20.0M on the company's adjusted measure, and Hippo kept 30% of what it wrote, down from 38%.
On the call, the finance chief said Hippo would keep a few points less again in 2027, and that its capital covers the 2028 plan. Management raised its 2026 forecast a second time, to $77M to $80M of adjusted profit.
What's happening now
The background
Fourth-quarter results in February 2027 are the next test: the 2027 premium forecast, the first full quarter of Accelerant's policies, and Accelerant's sale to Thoma Bravo, due to close in the first half of 2027.
Where we disagree
Both sides in full
The market
A home insurtech turned profitable and growing fast, rated a buy by four of six analysts.
We believe
A real, growing platform at a price that already pays for its 2028 plan, with profit still mostly on the company's adjusted measure.
The argument
Analysts see a home insurtech that has turned profitable and is growing fast. But the growth is mostly policies Hippo fronts for others and keeps little of, and on reported figures it earned about 6% on what shareholders own.
We would be wrong if reported profit passes $25M a quarter while Hippo keeps a third or more of what it writes.
What it's worth
How we value it
A lender, broker or insurer: debt is its raw material, so it is valued on its owners' equity plus the earnings above an 8% return on it, the equity growing on the analysts' path and the return on it from their earnings, then fading to 4% growth.
The three cases
Bear case$17.10
Equity grows at half that path, 15% and 12%, the return on equity settles a fifth lower at 7.9%, and new equity earns only the 8% rate: the downturn test.
Our value$20.90
Equity grows 30% and 24%, the analysts' revenue path (C34) held to 30% a year, then fades toward 4%; the return on equity moves to 9.8%, the analysts' last forecast year.
Bull case$48.24
Equity grows a quarter faster, 38% and 30%, the return on equity reaches 10.8%, and new equity earns 11%.
What could go wrong
Every risk
The risks
Accelerant could leave
Its biggest new partner, worth more than $500M a year of policies, is being bought by Thoma Bravo, and the agreement is not filed.
One programme drives casualty
Most casualty growth comes from one long-standing programme, so its loss would cut the fastest-growing line.
Storms and fires
Policies are concentrated in California, Texas, New York and Florida, and a bad season can wipe out a year of profit.
Fees could fall
Markel and others rent paper too, and Hippo does not disclose what fee it earns or whether it is holding.
Adjusted is not reported
Adjusted profit leaves out about $42M a year of stock pay and amortisation, which owners bear.
What we still do not know
How long the Accelerant agreement runs, and whether its new owner can end it.
What fee Hippo earns on the policies it fronts, and whether it is falling.
How much of casualty growth comes from the one long-standing programme.
What changes our view
Every route to a new view
Every route to a new view
→ Neutral
The share price falls to about $25.08, back within 20% of what we think the business is worth.
→ Attractive
The share price falls to about $16.72, 80% of what we think the business is worth.
→ Attractive
Reported net income reaches $25M in a quarter, up from $10.1M in the second quarter of 2026. In the same quarter Hippo keeps a third or more of the policies it writes.
The next test
It supports the case if
2027 gross written premium guided at or above $1.8B, the quarter's combined ratio at or below 101% and Accelerant's premium visible on Spinnaker paper.
It pressures the case if
2027 premium guided below $1.8B, a combined ratio above 105% without a named catastrophe, or Accelerant's programme moved or delayed.
We would also be wrong if
Accelerant moves its programme off Hippo's paper after its sale.
Policies written in 2027 are forecast below $1.8B in February.
The verdict
Scores and how we weighed it
The scores
Growth
3 of 4
Business quality
2 of 4
Financial position
3 of 4
Execution record
3 of 4
Per share capture
3 of 4
Potential
2 of 4
Risk profile
3 of 4
Valuation
2 of 4
Evidence quality
3 of 4
How we weighed it
ValueNegative
The price sits above our value, though the bull case is far higher.
BusinessMixed
A mixed business: fast growth, but it keeps little of what it writes.
GrowthPositive
Growth, costs and the forecast met our test.
RisksNegative
Its largest new partner may leave, one programme drives casualty and storms and fires concentrate risk.
RivalsMixed
In the middle of the home insurers it names.
The groupMixed
It sits in none of our ranked groups; catastrophe seasons move it.
Latest newsMixed
The last report met the test but reported profit fell well under adjusted.